Methyl(1R,5S,6r)-3-azabicyclo[3.1.0]hexane-6-carboxylatehydrochloride
95%
- Product Code: 213949
CAS:
1212063-26-7
Molecular Weight: | 177.63 g./mol | Molecular Formula: | C₇H₁₂ClNO₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical synthesis as a chiral building block for developing neuroactive compounds, particularly in the production of sigma receptor ligands and potential treatments for neurological disorders such as depression, anxiety, and neuropathic pain. Its rigid bicyclic structure supports high selectivity and binding affinity in receptor-targeted drugs. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its stereochemical stability and ability to mimic bioactive peptide conformations.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿2,570.00 |
+
-
|
Methyl(1R,5S,6r)-3-azabicyclo[3.1.0]hexane-6-carboxylatehydrochloride
Used in pharmaceutical synthesis as a chiral building block for developing neuroactive compounds, particularly in the production of sigma receptor ligands and potential treatments for neurological disorders such as depression, anxiety, and neuropathic pain. Its rigid bicyclic structure supports high selectivity and binding affinity in receptor-targeted drugs. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its stereochemical stability and ability to mimic bioactive peptide conformations.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :